** Fresenius Medical Care FMEG.DE falls 5% to the bottom of the STOXX 600 .STOXX after the dialysis firm confirms its outlook, but disappoints expectations for a small earnings beat linked to one-offs such as TDAPA ** J.P. Morgan warns Q1 may mark an earnings high point, with Transitional Drug Add-On Payment Adjustment (TDAPA) tailwinds of around 80 million euros ($93 million) in Q1 set to turn into headwinds in H2 ** "Heading into the print, expectations were elevated for an EBIT beat given one-offs benefiting the quarter, mostly TDAPA," BofA says ** "Outlook confirmed. After the recent recovery, this may not be good enough," a local trader says
($1 = 0.8557 euros)
(Reporting by Bartosz Dabrowski and Sanne Schimanski)
((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))